StockDriftsStockDriftsTop 4 Ponoi Ii Management, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 44.41% | 1.30M | $17K | new | — | 2022-09-30 | |
| RVMD | Revolution Medicines Inc | 35.31% | 685.0K | $14K | new | — | 2022-09-30 | |
| NRIX | Nurix Therapeutics Inc | 11.14% | 327.1K | $4K | new | — | 2022-09-30 | |
| RAPT | RAPT Therapeutics Inc | 9.14% | 145.4K | $3K | new | — | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Ponoi Ii Management, Llc reports $38.26K in US-listed equity holdings across 4 positions in its most recent 13F filing. Its largest disclosed positions are NGM (44.4%), RVMD (35.3%) and NRIX (11.1%). Figures reflect the Q3 2022 filing.
Sign up free to track Ponoi Ii Management, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Ponoi Ii Management, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1746488). View Ponoi Ii Management, Llc’s 13F filings on SEC